NDC Package 51754-0502-3 Caffeine Citrate

Injection Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51754-0502-3
Package Description:
10 VIAL, SINGLE-DOSE in 1 CARTON / 3 mL in 1 VIAL, SINGLE-DOSE (51754-0502-1)
Product Code:
Proprietary Name:
Caffeine Citrate
Non-Proprietary Name:
Caffeine Citrate
Substance Name:
Caffeine Citrate
Usage Information:
This medication is used for the short-term treatment of a breathing problem (apnea) in premature infants. Caffeine blocks certain proteins (adenosine receptors) which lead to improved breathing in these infants.
11-Digit NDC Billing Format:
51754050203
NDC to RxNorm Crosswalk:
  • RxCUI: 849931 - caffeine citrate 60 MG in 3 ML Injection
  • RxCUI: 849931 - 3 ML caffeine citrate 20 MG/ML Injection
  • RxCUI: 849931 - caffeine citrate 20 MG/ML (caffeine base 10 MG/ML) Injection
  • RxCUI: 849931 - caffeine citrate 60 MG per 3 ML Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Exela Pharma Sciences, Llc
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA077233
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    09-21-2006
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 51754-0502-3?

    The NDC Packaged Code 51754-0502-3 is assigned to a package of 10 vial, single-dose in 1 carton / 3 ml in 1 vial, single-dose (51754-0502-1) of Caffeine Citrate, a human prescription drug labeled by Exela Pharma Sciences, Llc. The product's dosage form is injection and is administered via intravenous form.

    Is NDC 51754-0502 included in the NDC Directory?

    Yes, Caffeine Citrate with product code 51754-0502 is active and included in the NDC Directory. The product was first marketed by Exela Pharma Sciences, Llc on September 21, 2006 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 51754-0502-3?

    The 11-digit format is 51754050203. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-151754-0502-35-4-251754-0502-03